600812 logo

North China Pharmaceutical Company.Ltd Stock Price

SHSE:600812 Community·CN¥7.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

600812 Share Price Performance

CN¥4.20
-1.95 (-31.71%)
CN¥4.20
-1.95 (-31.71%)
Price CN¥4.20

600812 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Average dividend payer with acceptable track record.

2 Risks
1 Reward

North China Pharmaceutical Company.Ltd Key Details

CN¥8.8b

Revenue

CN¥6.1b

Cost of Revenue

CN¥2.7b

Gross Profit

CN¥2.6b

Other Expenses

CN¥161.0m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.094
31.11%
1.83%
160.3%
View Full Analysis

About 600812

Founded
1992
Employees
9972
CEO
Li Xin Wang
WebsiteView website
ncpc.com

North China Pharmaceutical Company.Ltd engages in the research and development, production, and sales of pharmaceutical products in China and internationally. The company primarily offers anti-infective drugs, biotechnology drugs, cardiovascular cerebrovascular, immunomodulators, and vitamins and health products. It also provides chemical, biological, agricultural, and veterinary drugs. It serves pharmaceutical distributors, agents, hospitals, chain pharmacies, and end-user clinics. North China Pharmaceutical Company.Ltd was founded in 1992 and is headquartered in Shijiazhuang, China.

Recent 600812 News & Updates

Recent updates

No updates